What medication is recommended for a patient with bladder spasms, urinary retention, and hematuria with a Foley (Foley catheter) in place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bladder Spasms in Patients with Urinary Retention and Hematuria with Foley Catheter

Oxybutynin is the recommended first-line medication for managing bladder spasms in patients with urinary retention and hematuria who have a Foley catheter in place, at a dose of 0.2 mg/kg given orally three times daily.

Pathophysiology and Assessment

Bladder spasms commonly occur in patients with indwelling Foley catheters due to:

  • Irritation of the bladder trigone by the catheter balloon
  • Bladder wall irritation from hematuria
  • Detrusor muscle overactivity in response to the foreign body

Assessment Points:

  • Determine severity and frequency of spasms
  • Evaluate the degree of hematuria (mild, moderate, severe)
  • Assess for signs of catheter obstruction from blood clots
  • Rule out catheter-related complications (e.g., malposition, balloon overinflation)

Medication Management

First-Line Therapy:

  • Oxybutynin 0.2 mg/kg orally three times daily 1
    • Mechanism: Antimuscarinic agent that reduces detrusor overactivity
    • Directly indicated for treatment of detrusor overactivity in neurogenic bladder

Precautions with Oxybutynin:

  • Monitor for anticholinergic side effects including:
    • Dry mouth, constipation, blurred vision
    • Confusion, somnolence (particularly in elderly patients)
    • Potential urinary retention (though less concerning with catheter in place) 2
  • Use with caution in:
    • Elderly patients
    • Patients with hepatic or renal impairment
    • Patients with gastrointestinal disorders 2

Catheter Management

Proper Catheter Care:

  • Ensure catheter is properly secured to prevent movement and urethral trauma 3
  • Maintain closed drainage system to prevent bacterial entry 3
  • Consider using a larger caliber catheter (18-20 Fr) if hematuria with clots is present
  • Remove catheter as soon as clinically appropriate, ideally within 24-48 hours if possible 3

Bladder Irrigation:

  • For moderate to severe hematuria with clots:
    • Continuous or intermittent bladder irrigation with normal saline
    • Monitor for clot retention and obstruction
    • Ensure adequate outflow to prevent bladder distension

Additional Supportive Measures

Hydration:

  • Maintain adequate hydration to:
    • Dilute urine and reduce irritation
    • Help prevent clot formation
    • Facilitate clearance of hematuria 3

Pain Management:

  • Acetaminophen or NSAIDs for mild to moderate pain
  • Avoid opioids if possible due to risk of urinary retention 4
  • Consider warm compresses to lower abdomen for comfort

Monitoring and Follow-up

Daily Assessment:

  • Monitor urine characteristics (color, presence of clots)
  • Assess for signs of infection (fever, cloudy urine)
  • Evaluate continued need for catheterization 3
  • Document catheter days and complications

Indications for Specialist Referral:

  • Persistent severe hematuria despite management
  • Signs of catheter-related trauma or perforation 5, 6
  • Failure to respond to conservative management

Special Considerations

Catheter Removal:

  • Trial removal when hematuria resolves and patient's condition stabilizes
  • Consider alpha-blocker therapy prior to catheter removal in patients with urinary retention 1
  • Have contingency plan if recatheterization is needed

Surgical Considerations:

  • Surgery may be indicated for patients with:
    • Refractory urinary retention
    • Recurrent UTIs
    • Recurrent gross hematuria
    • Bladder stones due to BPH 1

By following this structured approach to managing bladder spasms in patients with urinary retention and hematuria with Foley catheters, clinicians can effectively control symptoms while minimizing complications and optimizing patient comfort.

Related Questions

What is the management for a patient with urinary obstruction and gross hematuria requiring catheterization with a Foley catheter?
What is the management plan for a 72-year-old male with hematuria (blood in urine) for 5 days after Foley catheter (indwelling urinary catheter) placement?
What is the next step for a 72-year-old man with an in-dwelling catheter (indwelling urinary catheter) who pulled it out and had it replaced, now experiencing persistent hematuria (blood in urine) after initial bladder irrigation?
What is the management for gross hematuria in a patient with a Foley catheter?
What is the next step in management for an 86-year-old male with urinary retention, gross hematuria, and low-grade fever after placement of a Foley catheter and initiation of broad-spectrum antibiotics (CBI - Community Acquired Bacterial Infection), should a CT scan of the abdomen and pelvis (CT A/P) be ordered?
What is the treatment for diverticulitis?
What is the next best antihypertensive agent after Angiotensin-Converting Enzyme (ACE) inhibitors/Angiotensin Receptor Blockers (ARB), Calcium Channel Blockers (CCB), and thiazide diuretics?
Is it reasonable to start low dose Lexapro (escitalopram) and hydroxyzine to prevent mast cell activation inflammation?
How close together can Starlix (nateglinide) be taken when eating smaller, more frequent meals?
What are the considerations for nasogastric (NG) tube placement and suction level to decompress the stomach in a patient with an upper gastrointestinal (UGI) bleed?
What can be done about emotional blunting after taking Adderall (amphetamine and dextroamphetamine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.